BioLight Reports 2015 Financial Results

BioLight Life Sciences reported operational and financial results for the year ended December 31, 2015.  Results were characterized by continued development and commercial progress in multiple markets, and the achievement of all previously announced 2015 milestones.

Operational Highlights:

  • Completed an upsized private investment and signed a strategic partnership with … Continue reading

Third Quarter 2015 Financial Results

BioLight today reported operational and financial results for the third quarter ended September 30, 2015.

Operational Highlights:

  • Reported first IOPtiMate™ System sales and additional distribution agreements, both in new territories.
  • Completed enrollment into the second U.S. clinical study in which TeaRx’s effectiveness is being assessed in tears … Continue reading